NEW YORK–(BUSINESS WIRE)–Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood,” “we,” “us” or “our”) today reacted to the proxy statement supplement filed by STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA) with respe…
Immunotherapy for Cat Allergy Shows Favorable Safety Profile
A depigmented polymerized cat allergoid is safe and generally well tolerated in patients with cat-induced allergic rhinitis, a real-world study finds. Medscape Medical News
Uncategorized
Microscope heads-up module offers improved ergonomics
ORLANDO — Haag-Streit has launched its Metis 3D Digital Heads-Up Module, according to a company press release.The module (Metis HU) expands on the company’s Metis 900 ophthalmic microscope by incorporating a 3D 4K camera and 55-inch monitor and replaci…
Uncategorized
Exploring AI scribe’s place in health care
Ambient listening documentation may soon become integral to clinical practice as AI advances reshape care delivery.Ambient scribes are poised to become one of the fastest technology adoptions in health care history, according to a March 2025 report on …
Uncategorized
Repeated CXL efficacious in patients with ectasia
COPENHAGEN, Denmark— Recent evidence supports repeated corneal cross-linking as an effective and safe option for patients with progressive ectasia following primary CXL failure.Results from a study evaluating repeated CXL (re-CXL) conducted at the ELZA…
Is Tirzepatide Easier on the Eyes Than GLP-1s?
Using tirzepatide is linked to lower risks of developing primary open-angle glaucoma and elevated eye pressure in patients with type 2 diabetes than using GLP-1 receptor agonists, a study finds. Medscape Medical News